Voya Financial Advisors Inc. grew its position in The Clorox Company (NYSE:CLX) by 4.6% in the fourth quarter, HoldingsChannel reports. The institutional investor owned 3,343 shares of the company’s stock after acquiring an additional 147 shares during the period. Voya Financial Advisors Inc.’s holdings in The Clorox were worth $672,000 at the end of the most recent quarter.
Other hedge funds and other institutional investors have also recently modified their holdings of the company. Iron Horse Wealth Management LLC acquired a new stake in shares of The Clorox in the fourth quarter valued at $25,000. McCarthy Asset Management Inc. acquired a new stake in shares of The Clorox in the fourth quarter valued at $38,000. Fort Pitt Capital Group LLC acquired a new stake in shares of The Clorox in the fourth quarter valued at $40,000. Oder Investment Management LLC acquired a new stake in shares of The Clorox in the fourth quarter valued at $43,000. Finally, Advisory Alpha LLC purchased a new position in The Clorox in the third quarter valued at $46,000. 81.73% of the stock is owned by institutional investors and hedge funds.
CLX has been the subject of a number of recent research reports. Atlantic Securities upgraded The Clorox from a “neutral” rating to an “overweight” rating and set a $233.00 target price for the company in a report on Thursday, February 25th. DA Davidson reiterated a “neutral” rating and issued a $189.00 target price on shares of The Clorox in a report on Wednesday, March 24th. Citigroup Inc. 3% Minimum Coupon Principal Protected Based Upon Russell upgraded The Clorox from a “neutral” rating to a “buy” rating and lifted their target price for the company from $238.00 to $249.00 in a report on Sunday, December 13th. Wells Fargo & Company reiterated a “buy” rating and issued a $240.00 target price on shares of The Clorox in a report on Wednesday, February 10th. Finally, Morgan Stanley decreased their price target on The Clorox from $190.00 to $182.00 and set an “underweight” rating for the company in a report on Thursday, January 14th. Three analysts have rated the stock with a sell rating, ten have given a hold rating and four have issued a buy rating to the stock. The stock has a consensus rating of “Hold” and a consensus target price of $216.65.
The Clorox (NYSE:CLX) last released its earnings results on Wednesday, February 3rd. The company reported $2.03 earnings per share (EPS) for the quarter, topping the Thomson Reuters’ consensus estimate of $1.78 by $0.25. The company had revenue of $1.84 billion for the quarter, compared to analysts’ expectations of $1.75 billion. The Clorox had a return on equity of 132.72% and a net margin of 16.14%. The firm’s quarterly revenue was up 27.1% on a year-over-year basis. During the same quarter in the previous year, the firm posted $1.46 EPS. Analysts expect that The Clorox Company will post 8.03 earnings per share for the current fiscal year.
The company also recently declared a quarterly dividend, which will be paid on Friday, May 7th. Stockholders of record on Wednesday, April 21st will be paid a dividend of $1.11 per share. This represents a $4.44 annualized dividend and a dividend yield of 2.29%. The ex-dividend date of this dividend is Tuesday, April 20th. The Clorox’s dividend payout ratio (DPR) is 60.33%.
In other news, CFO Kevin B. Jacobsen sold 35,176 shares of the business’s stock in a transaction that occurred on Monday, January 25th. The stock was sold at an average price of $215.00, for a total transaction of $7,562,840.00. Following the sale, the chief financial officer now owns 26,491 shares of the company’s stock, valued at approximately $5,695,565. The sale was disclosed in a filing with the Securities & Exchange Commission, which is available through this hyperlink. Also, COO Eric H. Reynolds sold 3,147 shares of the business’s stock in a transaction that occurred on Monday, January 25th. The stock was sold at an average price of $214.07, for a total value of $673,678.29. Following the sale, the chief operating officer now directly owns 16,997 shares in the company, valued at approximately $3,638,547.79. The disclosure for this sale can be found here. 1.09% of the stock is owned by insiders.
The Clorox Company Profile
The Clorox Company manufactures and markets consumer and professional products worldwide. It operates through four segments: Health and Wellness, Household, Lifestyle, and International. The company offers laundry additives, including bleach products under the Clorox brand, as well as Clorox 2 stain fighter and color booster; home care products primarily under the Clorox, Scentiva, Formula 409, Liquid-Plumr, Pine-Sol, S.O.S, and Tilex brands; naturally derived products under the Green Works brand; professional cleaning, disinfecting, and food service products under the CloroxPro, Clorox Healthcare, and Clorox Total 360 brands; professional food service products under the Hidden Valley brand; and vitamins, minerals, and supplement products under the RenewLife, Rainbow Light, Natural Vitality, NeoCell, and Stop Aging Now brands.
Featured Article: Bear Market – How and Why They Occur
Want to see what other hedge funds are holding CLX? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for The Clorox Company (NYSE:CLX).
Receive News & Ratings for The Clorox Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for The Clorox and related companies with MarketBeat.com's FREE daily email newsletter.